Neurogene (NGNE) Change in Cash (2013 - 2026)

Neurogene's Change in Cash history runs 14 years deep, the most recent figure standing at $20.3 million for Q1 2026.

• Quarterly Change in Cash rose 130.87% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.4 million (up 167.27% YoY) and the FY2025 annual result came in at -$32.7 million, down 177.63% from the prior year.
• Change in Cash was $20.3 million for Q1 2026 at Neurogene, down from $32.8 million in the prior quarter.
• Across five years, Change in Cash topped out at $113.6 million in Q4 2022 and bottomed at -$65.8 million in Q1 2025.
• A 5-year average of $3.2 million and a median of -$12.0 million in 2025 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash surged 1012.01% — and 2025, when it tumbled 3837.37%.
• Neurogene's Change in Cash stood at $113.6 million in 2022, then decreased by 9.2% to $103.2 million in 2023, then slumped by 32.19% to $70.0 million in 2024, then tumbled by 53.05% to $32.8 million in 2025, then plunged by 38.14% to $20.3 million in 2026.
• Business Quant data shows NGNE's Change in Cash at $20.3 million in Q1 2026, $32.8 million in Q4 2025, and $12.2 million in Q3 2025.